accountdeveloper, with some 400 marketing authorizations licensed to third parties for sale in 36 countries, including France, Germany, Poland, Italy and Spain. Watson had revenue of nearly $3.6 billion last year. JP Morgan analyst Chris Schott said Watson's...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Watson Pharmaceuticals buys generic drug developer Specifar
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account